immunonutrition supplement of ORAL IMPACT™
Dietary SupplementFor intervention group, patients will take immunonutrition supplement after recruitment until the day before surgery.
NCT Number: NCT05971810
The goal of this multicenter randomized controlled trial is to explore the efficacy of perioperative oral decontamination and immunonutrition supplement to prevent postoperative pulmonary complications in elderly patients(≥65 years) receiving elective non-cardiac operations. Participants will be either given immunonutrition supplement versus routine nutrition advice, and oral chlorhexidine decontamination versus routine oral care randomly. The two interventions will be compared with control groups separately regarding postoperative pulmonary complications and other outcomes.
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Not applicable
The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
This study is a prospective, multicenter, two-by-two factorial randomized controlled trial evaluating the efficacy of immunonutrition supplementation and oral chlorhexidine decontamination. Patients aged 65 years and older who are scheduled for elective non-cardiac surgeries will be recruited. Participants will be excluded if they have contraindication to the intervention. The patients will be randomized into four groups in 1:1:1:1 ratio (oral decontamination vs routine oral care, immunonutrition supplementation vs routine nutrition advice). The primary outcome is the incidence of postoperative pulmonary complications within 7 days after surgery. Secondary outcomes include incidence of pneumonia, infectious complications, comprehensive complication index, postoperative functional recovery, length of hospital stay and hospital expense.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For intervention group, patients will take immunonutrition supplement after recruitment until the day before surgery.
For intervention group, patients will use 0.12% chlorhexidine for oral rinse twice daily from the day before surgery until 3 days after surgery.
Time frame: within 7 days after surgery
composite outcome of postoperative pulmonary complications, including pneumonia, atelectasis, pneumothorax, bronchospasm, pleural effusion, hypoxemia, acute respiratory failure, prolonged mechanical ventilation, unplanned re-intubation,etc.
Time frame: within 7days and 30 days after surgery
defined according to the US Centers for Disease Control Definition
Time frame: within 30 days after surgery
composite outcome of postoperative pulmonary complications, including pneumonia, atelectasis, pneumothorax, bronchospasm, pleural effusion, hypoxemia, acute respiratory failure, prolonged mechanical ventilation, unplanned re-intubation,etc.
Time frame: within 7days and 30 days after surgery
composite outcome including surgical site infection, respiratory infection, urinary tract infection, intra-abdominal infection, blood stream infection, etc.
Time frame: within 7days and 30 days after surgery
defined using comprehensive complication index
Time frame: within 7days and 30 days after surgery
assessed by 15-item quality of recovery questionnaire and WHO disability assessment schedule 2.0
Time frame: upon hospital discharge, typically 1-2 weeks
total expense during the hospital stay
Time frame: upon hospital discharge,typically 1-2 weeks
days of in hospital stay
Contact information is provided by the study sponsor or research team.
Peking Union Medical College Hospital
Other
Perioperative Oral Decontamination and ImmunoNuTrition (POINT) on Postoperative Pulmonary Complications in Elderly: a Multicenter Randomized Controlled Trial
Acronym: POINT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04663958
Abdominal Surgery, Atelectasis
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT05886387
Mechanical Ventilation Complication, Pathologic Processes
São Paulo, Brazil
View Trial DetailsNCT05502926
Anesthesia, Pathologic Processes
Beersheba, Israel
View Trial DetailsNCT06173583
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Karachi, Sindh, Pakistan
View Trial Details